Welcome to our dedicated page for Amphenol SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amphenol Corporation filings document the company’s operating results, capital structure, governance and material-event disclosures as a global supplier of connectors, interconnect systems, antennas, sensors and specialty cable products. Form 8-K reports cover quarterly and annual financial results, completed acquisition activity, material agreements, debt offerings and board succession matters.
APH proxy materials address director elections, executive compensation, auditor ratification, stockholder voting procedures and beneficial ownership. Registration and current-report filings also disclose Class A common stock, listed senior notes, unsecured note guarantees by Amphenol, subsidiary financing activity, risk factors and other corporate governance and capital-allocation matters.
Amphenol Corp (APH) executive Luc Walter reported a new stock option grant and updated share holdings. He received stock options for 108,809 shares of Class A Common Stock at an exercise price of $132.06 per share, expiring on May 22, 2036.
The options begin vesting on May 22, 2027 and become exercisable at 20% per year over five years. Following this filing, Walter directly holds 353,742 shares of Class A Common Stock, indicating a substantial ongoing equity stake in the company in addition to the new option award.
Amphenol Corp executive Peter Straub, President of the ISS Division, received a grant of stock options covering 108,809 shares of Class A Common Stock. The options have an exercise price of $132.0600 per share, vest 20% per year over five years starting on the first anniversary of the grant date, and expire on May 22, 2036. Following this award, the filing shows 108,809 stock options outstanding for Straub.
Amphenol Corporation executive David M. Silverman received a new stock option award tied to the company’s Class A Common Stock. On May 22, 2026, he was granted options for 70,690 shares at an exercise price of $132.06 per share, with no cash paid at grant.
The options become exercisable 20% per year over a five-year period starting on the first anniversary of the grant date and expire on May 22, 2036. This award is a compensation-related equity grant rather than an open-market purchase or sale.
Following the reported positions, Silverman holds 15,672 Amphenol Class A shares directly, which includes 3,172 shares transferred from his 2025 GRAT #1 since his last Form 4, and 10,828 shares indirectly through the David Michael Silverman 2025 GRAT #1, along with the newly granted 70,690 stock options.
Amphenol Corp President & CEO Richard Adam Norwitt reported a new stock option grant on Class A Common Stock. He received options covering 464,989 shares at an exercise price of 132.06 per share, exercisable starting on the first anniversary of the grant date.
According to the filing, the options vest at 20% per year over five years and expire on May 22, 2036. The report also lists existing holdings of Class A Common Stock held directly, indirectly through the Norwitt Family Trust, and some shares owned through his IRA, with no open-market buys or sells disclosed.
Amphenol Executive VP & CFO Craig A. Lampo reported updated holdings and a new equity award. He received a grant of 133,161 stock options on Class A Common Stock at an exercise price of $132.06 per share, expiring in 2036. The options begin to vest 20% per year over five years starting on the first anniversary of the grant date, aligning compensation with longer-term performance. The filing also lists his direct holding of 70,907 Class A shares and additional indirect holdings through several GRAT entities.
Ivas Michael R. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corp senior vice president and corporate controller Michael R. Ivas reported a new stock option grant linked to the company’s Class A Common Stock. He received options covering 51,134 shares, exercisable at $132.06 per share, expiring in 2036.
According to the footnote, these options become exercisable at 20% per year over five years, starting on the first anniversary of the grant date. The filing also lists his existing share positions, including 154,948 shares held directly and additional indirect holdings through his spouse, children, and a 2026 GRAT.
Amphenol Corp executive William J. Doherty, President of the CS Division, received a grant of stock options as part of his compensation. He was awarded 108,809 stock options, each giving the right to buy one share of Class A Common Stock at an exercise price of $132.06 per share.
The options start to become exercisable at a rate of 20% per year over five years, beginning on the first anniversary of the grant date, and will expire on May 22, 2036. The filing also shows that Doherty held 0 shares of Class A Common Stock directly after the reported transactions.
Amphenol EVP and General Counsel Lance E. D'Amico received a stock option award tied to the company’s Class A Common Stock. On May 22, 2026, he was granted options for 83,020 shares at an exercise price of $132.06 per share, vesting 20% per year over five years starting one year after the grant date and expiring on May 22, 2036.
Following this filing, D'Amico is reported as holding 57,065 shares of Class A Common Stock directly, plus 25,000 shares and 19,335 shares indirectly through the Lance E. D'Amico 2026 GRAT #1 and 2025 GRAT #1, respectively.
Wolff Anne Clarke reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Anne Clarke Wolff received a grant of 1,552 shares of Restricted Stock. The award was granted on May 22, 2026 at a stated price of $0.0000 per share as compensation, not a market purchase.
The grant was made under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. Following this award, Wolff directly holds 1,552 shares of Restricted Stock and 41,154 shares of Class A Common Stock reported as a holding entry.
Singh Prahlad R. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Prahlad R. Singh received a grant of 1,552 shares of Restricted Stock. The award was granted at a price of $0.0000 per share under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
Following this filing, Singh holds 11,376 shares of Class A Common Stock directly and 1,552 shares of Restricted Stock directly. The grant reflects equity-based compensation for his role as a director rather than an open-market purchase or sale.